<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03207594</url>
  </required_header>
  <id_info>
    <org_study_id>102472</org_study_id>
    <nct_id>NCT03207594</nct_id>
  </id_info>
  <brief_title>Improving Evidence-Based Care for Cancer Patients</brief_title>
  <official_title>Improving Evidence-Based Care for Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve cancer care and the delivery of cancer care.
      Researchers are interested in studying patient reported information and examining how
      different factors may impact cancer care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with biochemically confirmed smoking cessation</measure>
    <time_frame>4 weeks after enrollment</time_frame>
    <description>Biochemical confirmation will be determined by saliva samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patient who self-report smoking cessation</measure>
    <time_frame>4 weeks after enrollment</time_frame>
    <description>Self-reported smoking cessation will be documented via smoking assessment questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average weekly smoke exposure</measure>
    <time_frame>up to 62 weeks</time_frame>
    <description>reported cigarettes per day multiplied by the number of days smoked during radiation therapy (RT), summed over a period of time and normalized to yield an average weekly smoke exposure during RT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who participate in smoking cessation</measure>
    <time_frame>up to 12 months after completion of RT.</time_frame>
    <description>Completing one in-person visit where an individualized smoking cessation treatment plan is developed and implemented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with smoking cessation</measure>
    <time_frame>up to 12 weeks after completion of RT</time_frame>
    <description>Two binary measure of compliance:
- completing at least three in person visits within 6 weeks of starting an individualized cessation treatment plan
- completing at least one in-person visit and at least two phone-based communications</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">276</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Prostate Cancer</condition>
  <condition>Breast Cancer</condition>
  <condition>Lung Cancer</condition>
  <condition>Gynecologic Cancer</condition>
  <condition>Gastrointestinal Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <description>Current smokers with cancer who are planning to get radiation therapy at MUSC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey</intervention_name>
    <description>Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saliva sample</intervention_name>
    <description>Subjects will have saliva collected by a member of the study team using a cotton swab.</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Smoking Status questions</intervention_name>
    <description>Subjects will be asked to complete an assessment asking questions about his/her current smoking status</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic
             cancer

          -  21 years of age or older at time of study registration

          -  Must have been referred to MUSC radiation oncology for treatment with curative
             radiation therapy

          -  Must report current smoking defined as self-reporting smoking within the past 30 days
             using a structured intake questionnaire.

        Exclusion Criteria:

          -  Patients with primary central nervous system malignancies will be excluded.

          -  Patients that have other cancer disease types will be excluded due to either
             significant differences in standard radiation therapy approaches or rarity of disease
             required radiation.

          -  Patients who are currently participating in the Medical University of South Carolina
             Hollings Cancer Center smoking cessation program

          -  Patients who are unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graham Warren, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Annand, MSHP</last_name>
    <phone>843-792-7358</phone>
    <email>annands@musc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Annand</last_name>
      <phone>843-792-9321</phone>
      <email>hcc-clinical-trials@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 22, 2017</study_first_submitted>
  <study_first_submitted_qc>June 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

